Table 1.

Corticosteroid dosage and anti-dsg3 AAb level. Patient's follow-up.

Time	Deltacortene (mgs/die)	IIF Titer
Prior to May 2004	100	1:400
May 2004*	50	1:200
November 2004	20	1:100
February 2005	20	1:100
March 2006	20	1:100

* Topical peptide treatment given.